Indian Army Department Of Military Affairs Medical Supplies Tender North 24 Parganas West Bengal 2026 - ISI/ISO Standards & 25% Qty Flexibility

Tender Overview

Organization: Indian Army, Department Of Military Affairs. Product/Service: Procurement of multiple pharmaceutical products including tablets, injections, and eye drops (Tab Methylcobalmine 1500 mcg, Cap Fluconazole 150 mg, Tab Betahistine 8 mg, Inj Multivitamin 10 ml, Inj Hyoscine bromide 1 ml, Inj Adrenaline 1 ml, Inj Paracetamol 1000 mg (bottle 100 ml), Tab Common cold, Inj Pheniramine 2 ml, Tab Pheniramine 25 mg, Inj Paracetamol 2 ml, Inj Ondansetron 2 ml, Tab Ondanis 8 mg, Tab Telmisartan 40 mg, Inj Dicyclomine 2 ml, Tab Dextrpomethorphin logenzes 5 mg, Eye drop Carboxymethyl cellulose 5 ml). Location: North 24 Parganas, West Bengal (700057). BOQ: 17 items; quantities not specified. Estimated value/EMD: Not disclosed. Key differentiator: Option Clause enabling ±25% quantity variation at contract and during currency with contracted rates; delivery timeline tied to last original DO date. The purchase supports general medical supply needs for the Indian Army.

Technical Specifications & Requirements

• No explicit technical specifications provided in the tender data.
• Product/service names drawn from the bid listing include a range of pharmaceuticals and ophthalmic drops: Methylcobalmine 1500 mcg tablets, Fluconazole 150 mg capsules, Betahistine 8 mg tablets, Injections: Multivitamin 10 ml, Hyoscine bromide 1 ml, Adrenaline 1 ml, Paracetamol 1000 mg (bottle 100 ml), Pheniramine 2 ml, Pheniramine 25 mg tablets, Ondansetron 2 ml injections and 8 mg tablets, Telmisartan 40 mg tablets, Dicyclomine 2 ml injection, Dextromethorphan/Logenzes 5 mg tablets, Carboxymethyl cellulose eye drops 5 ml.
• Standards/Certifications: Not specified in the tender data.
• Delivery/Installation: Delivery period linked to original delivery order; option period calculated as (Increased quantity ÷ Original quantity) × Original delivery period with a minimum of 30 days.
• Experience/Capability: Not specified; requires compliance with the purchaser’s option clause and delivery terms.
• Warranty/Support: Not specified in the provided terms.

Terms, Conditions & Eligibility

• EMD/Security: Not disclosed in the tender document.
• Delivery: Delivery period calculated as above; extended duration may apply up to the original delivery period.
• Option Clause: Quantity may be increased or decreased by up to 25% at contract placement and during currency at contracted rates.
• Payment Terms: Not specified.
• Documentation: Not specified; bidders should anticipate standard bid submissions per policy and the organization’s requirements.
• Eligibility: Compliance with option clause and ability to supply multiple pharmaceutical products; no explicit minimum years of experience or turnover stated in the data provided.
• Penalties/LD: Not detailed in the supplied terms.